Cód QR

Citicoline Triggers Proteome Remodeling and Proteostatic Adaptation: Evidence from Shotgun Proteomics

<b>Background/Objectives</b>: Citicoline, also known as CDP-choline, is a nootropic agent currently used in the treatment of glaucoma and is undergoing evaluation as a first-line therapy in a multi-center, international, phase III, randomized clinical trial involving citicoline eyedrops (ClinicalTri...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Dario Cavaterra, Sara Giammaria, Irene Pandino, Gabriele Antonio Zingale, Valerio Delli Paoli, Rebecca Fiore, Manuele Michelessi, Gloria Roberti, Carmela Carnevale, Lucia Tanga, Daniela Cazzato, Elisa Peroni, Giuseppe Grasso, Gianluca Manni, Alessio Bocedi, Francesco Oddone, Massimiliano Coletta, Diego Sbardella, Grazia Raffaella Tundo
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: MDPI AG 2026-01-01
Sraith:Pharmaceutics
Ábhair:
citicoline
glaucoma
proteomics
proteostasis
proteasome
Rochtain ar líne:https://www.mdpi.com/1999-4923/18/1/61
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla